Patient perceptions of prandial oral therapy for type 2 diabetes

The Diabetes Educator

Volumn 27, Issue 5, 2001, Pages 669-677

  Bonneville, Miohele ^a   Colgin, Joan ^a   Nalesnick, Jo Ann ^a   Perez, Joan ^a   Wentz, Lynne ^a  

^a NOVO NORDISK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CARBAMIC ACID DERIVATIVE; METFORMIN; PIPERIDINE DERIVATIVE; REPAGLINIDE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD; DRUG ADMINISTRATION; DRUG COMBINATION; EATING; FEMALE; HUMAN; HYPOGLYCEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADMINISTRATION, ORAL; ADULT; AGED; ATTITUDE TO HEALTH; CARBAMATES; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EATING; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PIPERIDINES; QUESTIONNAIRES;

EID: 0035469319     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170102700507     Document Type: Article

References (10)

1. Ratner RE. Repaglinide therapy in the treatment of type 2 diabetes. Today's Ther Trends. 1999;17:57-66.
2. Balfour JA, Faulds D. Repaglinide. Drugs Aging. 1998;13:173-180.
3. Jovanovic L. Rationale for prevention and treatment of postprandial glucose-mediated toxicity. Endocrinologist. 1999;9:87-92.
4. DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 1999; 354:617-621.
5. Damsbo P, Clauson P, Marbury TC, Windfeld K. A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients. Diabetes Care. 1999;22:789-794.
6. Repaglinide (Prandin®) product labeling. Physicians Desk Reference. 55th ed. Montvale, NJ: Medical Economics Co; 2001: 2245-2247.
7. Ceriello A. The emerging role of postprandial hyperglycaemic spikes in the pathogenesis of diabetic complications. Diabetic Med. 1998;15:188-193.
8. Balkau B, Bertrais S, Ducimetiere P, Eschwege E. Is there a glycemic threshold for mortality risk? Diabetes Care. 1999;22:696-699.
9. Barzilay JI, Spiekerman CF, Wahl PW, et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999;354: 622-625.
10. Bastyr EJ III, Stuart CA, Brodows RG, et al, for the IOEZ Study Group. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care. 2000; 23:1236-1241.